{
    "hands_on_practices": [
        {
            "introduction": "The first step in evaluating compressive myelopathy is often to quantify the degree of physical cord deformity from imaging studies. This exercise guides you through a core task in quantitative neuroradiology: converting pixel-based measurements from a Magnetic Resonance Imaging (MRI) scan into true physical dimensions to calculate a cord compression ratio. This practice  demonstrates how a simple, objective geometric index provides a powerful, quantitative correlate for clinical severity, bridging the gap between imaging findings and patient function.",
            "id": "4470596",
            "problem": "A patient with cervical compressive myelopathy due to degenerative spondylosis is imaged with axial T2-weighted magnetic resonance imaging (MRI) at the intervertebral level C5–C6, where osteophytic ridging and ligamentous buckling cause anterior indentation of the spinal cord. The Digital Imaging and Communications in Medicine (DICOM) metadata report in-plane pixel spacing of $s_x = 0.45$ millimeters per pixel (left–right, transverse axis) and $s_y = 0.40$ millimeters per pixel (anterior–posterior axis). At four contiguous axial slices spanning the maximal compression, a trained rater uses a digital caliper to measure the spinal cord’s anteroposterior diameter ($n_{AP}$, in pixels along the $y$ axis) and transverse diameter ($n_{LAT}$, in pixels along the $x$ axis) at the cord’s centroid as follows: slice $A$: $n_{AP}=12$, $n_{LAT}=26$; slice $B$: $n_{AP}=11$, $n_{LAT}=27$; slice $C$: $n_{AP}=9$, $n_{LAT}=28$; slice $D$: $n_{AP}=10$, $n_{LAT}=25$.\n\nUsing the definition that the cord compression ratio at the maximally compressed level is the dimensionless ratio of the smallest anteroposterior diameter to the largest transverse diameter measured across the set of axial images at that level, compute this ratio by converting pixel counts to physical diameters before forming the ratio. Then, using widely observed clinical categorizations on the modified Japanese Orthopaedic Association (mJOA) scale—where severe myelopathy typically corresponds to $\\text{mJOA} \\leq 11$, moderate to $\\text{mJOA} \\in [12,14]$, and mild to $\\text{mJOA} \\in [15,17]$ (with normal function near $18$)—discuss which severity category is most consistent with the computed ratio based on the qualitative relationship between greater geometric compression and lower mJOA scores. Express the final ratio as a pure number without units, and round your answer to four significant figures.",
            "solution": "The problem statement has been evaluated and is deemed valid. It is scientifically grounded, well-posed, objective, and contains all necessary information for a unique solution. The data provided are consistent and realistic for a clinical neuroimaging scenario.\n\nThe objective is to compute the spinal cord compression ratio and discuss its clinical implications based on the given data.\n\nFirst, we must convert the pixel-based measurements into physical diameters in millimeters. The givens are the in-plane pixel spacings: $s_x = 0.45$ millimeters per pixel for the transverse (left–right) axis and $s_y = 0.40$ millimeters per pixel for the anteroposterior (AP) axis.\n\nThe measurements in pixels ($n_{AP}$, $n_{LAT}$) for the four contiguous axial slices are:\nSlice A: $n_{AP,A} = 12$, $n_{LAT,A} = 26$\nSlice B: $n_{AP,B} = 11$, $n_{LAT,B} = 27$\nSlice C: $n_{AP,C} = 9$, $n_{LAT,C} = 28$\nSlice D: $n_{AP,D} = 10$, $n_{LAT,D} = 25$\n\nThe physical anteroposterior diameter ($d_{AP}$) for each slice is calculated by multiplying its pixel count ($n_{AP}$) by the corresponding pixel spacing ($s_y$).\n$d_{AP,i} = n_{AP,i} \\times s_y$\n\nThe physical transverse, or lateral, diameter ($d_{LAT}$) for each slice is calculated by multiplying its pixel count ($n_{LAT}$) by the corresponding pixel spacing ($s_x$).\n$d_{LAT,i} = n_{LAT,i} \\times s_x$\n\nLet us compute these physical diameters for each slice.\n\nFor the anteroposterior diameters:\n$d_{AP,A} = 12 \\times 0.40 \\, \\text{mm} = 4.8 \\, \\text{mm}$\n$d_{AP,B} = 11 \\times 0.40 \\, \\text{mm} = 4.4 \\, \\text{mm}$\n$d_{AP,C} = 9 \\times 0.40 \\, \\text{mm} = 3.6 \\, \\text{mm}$\n$d_{AP,D} = 10 \\times 0.40 \\, \\text{mm} = 4.0 \\, \\text{mm}$\n\nFor the transverse diameters:\n$d_{LAT,A} = 26 \\times 0.45 \\, \\text{mm} = 11.7 \\, \\text{mm}$\n$d_{LAT,B} = 27 \\times 0.45 \\, \\text{mm} = 12.15 \\, \\text{mm}$\n$d_{LAT,C} = 28 \\times 0.45 \\, \\text{mm} = 12.6 \\, \\text{mm}$\n$d_{LAT,D} = 25 \\times 0.45 \\, \\text{mm} = 11.25 \\, \\text{mm}$\n\nThe problem defines the cord compression ratio ($R_c$) as the ratio of the smallest anteroposterior diameter to the largest transverse diameter measured across the set of images. We must identify these two values from our calculated physical diameters.\n\nThe set of AP diameters is $\\{4.8, 4.4, 3.6, 4.0\\}$ in millimeters. The smallest value is:\n$d_{AP, \\text{min}} = \\min(\\{4.8, 4.4, 3.6, 4.0\\}) = 3.6 \\, \\text{mm}$\n\nThe set of transverse diameters is $\\{11.7, 12.15, 12.6, 11.25\\}$ in millimeters. The largest value is:\n$d_{LAT, \\text{max}} = \\max(\\{11.7, 12.15, 12.6, 11.25\\}) = 12.6 \\, \\text{mm}$\n\nNow, we compute the compression ratio $R_c$:\n$$\nR_c = \\frac{d_{AP, \\text{min}}}{d_{LAT, \\text{max}}} = \\frac{3.6 \\, \\text{mm}}{12.6 \\, \\text{mm}}\n$$\nThe units of millimeters cancel, yielding a dimensionless ratio as required.\n$$\nR_c = \\frac{3.6}{12.6} = \\frac{36}{126} = \\frac{18}{63} = \\frac{2}{7}\n$$\nAs a decimal, this is $R_c \\approx 0.28571428...$. The problem requires rounding to four significant figures. The fifth significant figure is $1$, so we round down.\n$$\nR_c \\approx 0.2857\n$$\n\nFinally, we are asked to discuss which severity category is most consistent with this ratio. A normal, uncompressed spinal cord has a roughly circular or ovoid cross-section, with a compression ratio closer to $1$. The calculated ratio of approximately $0.2857$ indicates a profound flattening of the spinal cord, where its anteroposterior dimension is less than $30\\%$ of its transverse dimension. This represents a significant degree of geometric distortion. The problem states a qualitative relationship: greater geometric compression corresponds to lower modified Japanese Orthopaedic Association (mJOA) scores. The mJOA categories given are severe ($\\text{mJOA} \\leq 11$), moderate ($\\text{mJOA} \\in [12,14]$), and mild ($\\text{mJOA} \\in [15,17]$). Given the substantial geometric compression indicated by the ratio $R_c \\approx 0.2857$, it is most probable that the patient's clinical status corresponds to the severe myelopathy category ($\\text{mJOA} \\leq 11$). This finding quantitatively supports the diagnosis of compressive myelopathy due to the described spondylotic changes.",
            "answer": "$$\n\\boxed{0.2857}\n$$"
        },
        {
            "introduction": "Beyond identifying the presence of a compressive lesion, a critical next step in oncologic cases is to assess the risk of mechanical spinal instability, which can lead to catastrophic neurological injury. This exercise introduces the Spinal Instability Neoplastic Score (SINS), a validated and widely adopted clinical tool that systematically integrates multiple risk factors to guide treatment decisions. By working through the provided clinical vignette , you will practice applying this structured framework to stratify a patient's risk and determine the potential need for surgical stabilization.",
            "id": "4470697",
            "problem": "A 62-year-old person with metastatic renal cell carcinoma presents with progressive thoracic axial pain that is worse with sitting, standing, and rotation, and is relieved by recumbency. Over the past $3$ weeks, they have developed gait imbalance and hyperreflexia below the T10 dermatome. Magnetic resonance imaging demonstrates a T9 vertebral body lesion with epidural encroachment and spinal cord compression. Computed tomography shows a predominantly lytic lesion centered in the T9 vertebral body with extension into both pedicles, a focal kyphotic angulation of 12 degrees (express angles in degrees) without vertebral translation or subluxation, and approximately $60\\%$ loss of T9 vertebral body height. There is no prior instrumentation. The anatomical level T9 resides within the mid-thoracic spine (T3–T10).\n\nThe Spinal Instability Neoplastic Score (SINS) is a composite, category-based instrument derived from established biomechanical risk factors for failure of spinal structural integrity under physiologic loading. Using its standard rubric, assign points for each of the following domains:\n- Location: junctional regions (occipito-cervical, cervicothoracic, thoracolumbar, lumbosacral) $\\rightarrow 3$; mobile spine (C3–C6, L2–L4) $\\rightarrow 2$; semi-rigid spine (T3–T10) $\\rightarrow 1$; rigid spine (sacrum) $\\rightarrow 0$.\n- Pain: mechanical (load-dependent pain and/or relief with recumbency) $\\rightarrow 3$; occasional pain not mechanical $\\rightarrow 1$; no pain $\\rightarrow 0$.\n- Bone lesion quality: lytic $\\rightarrow 2$; mixed lytic/blastic $\\rightarrow 1$; blastic $\\rightarrow 0$.\n- Radiographic spinal alignment: subluxation or translation $\\rightarrow 4$; de novo deformity (kyphosis or scoliosis) without translation $\\rightarrow 2$; normal alignment $\\rightarrow 0$.\n- Vertebral body collapse: greater than one-half height loss $\\rightarrow 3$; less than or equal to one-half height loss $\\rightarrow 2$; no collapse $\\rightarrow 0$.\n- Posterolateral involvement of spinal elements (facet joints and/or pedicles): bilateral $\\rightarrow 3$; unilateral $\\rightarrow 1$; none $\\rightarrow 0$.\n\nCompute the total SINS for this lesion and, based on the composite score categories defined by the SINS framework (stable $0$–$6$, indeterminate $7$–$12$, unstable $13$–$18$), determine whether mechanical instability necessitates surgical stabilization. Report only the total SINS as your final numeric answer. Express the final score as an integer with no units.",
            "solution": "The problem requires the calculation of the Spinal Instability Neoplastic Score (SINS) for a patient with a metastatic lesion in the thoracic spine. The total score is determined by summing the points assigned to six individual domains based on the provided clinical and radiological findings. The calculation proceeds by systematically evaluating each domain.\n\n1.  **Location of Lesion**:\n    The lesion is located at the T9 vertebral body. The problem statement explicitly defines the anatomical region from T3 to T10 as the semi-rigid spine. According to the SINS rubric, a lesion in the \"semi-rigid spine (T3–T10)\" is assigned a score of $1$.\n    Score for Location = $1$.\n\n2.  **Pain Characteristics**:\n    The patient presents with \"progressive thoracic axial pain that is worse with sitting, standing, and rotation, and is relieved by recumbency.\" This description precisely matches the definition of mechanical pain. The SINS rubric for \"mechanical (load-dependent pain and/or relief with recumbency)\" assigns a score of $3$.\n    Score for Pain = $3$.\n\n3.  **Bone Lesion Quality**:\n    The computed tomography (CT) finding is a \"predominantly lytic lesion.\" The SINS rubric assigns a score of $2$ for a \"lytic\" bone lesion.\n    Score for Bone Lesion Quality = $2$.\n\n4.  **Radiographic Spinal Alignment**:\n    The imaging reveals \"a focal kyphotic angulation of $12$ degrees without vertebral translation or subluxation.\" This finding corresponds to a \"de novo deformity (kyphosis or scoliosis) without translation\" in the SINS rubric, which is assigned a score of $2$. The presence of subluxation or translation, which would warrant a higher score of $4$, is explicitly ruled out.\n    Score for Spinal Alignment = $2$.\n\n5.  **Vertebral Body Collapse**:\n    The CT scan shows \"approximately $60\\%$ loss of T9 vertebral body height.\" A loss of $60\\%$ is greater than one-half ($50\\%$) of the vertebral body height. The SINS rubric for \"greater than one-half height loss\" assigns a score of $3$.\n    Score for Vertebral Body Collapse = $3$.\n\n6.  **Posterolateral Involvement of Spinal Elements**:\n    The lesion demonstrates \"extension into both pedicles.\" The pedicles are posterolateral elements of the vertebra. Involvement of both pedicles constitutes bilateral involvement. The SINS rubric for \"bilateral\" posterolateral involvement (of facet joints and/or pedicles) assigns a score of $3$.\n    Score for Posterolateral Involvement = $3$.\n\n**Total SINS Calculation**:\nThe total SINS is the summation of the scores from the six domains:\nTotal SINS = (Score for Location) + (Score for Pain) + (Score for Bone Lesion Quality) + (Score for Spinal Alignment) + (Score for Vertebral Body Collapse) + (Score for Posterolateral Involvement)\nTotal SINS = $1 + 3 + 2 + 2 + 3 + 3 = 14$.\n\n**Interpretation**:\nThe total SINS is $14$. According to the provided composite score categories, a score in the range of $13$–$18$ signifies an \"unstable\" spine. This finding indicates that mechanical instability is present, and surgical consultation for potential stabilization is warranted. The problem, however, asks only for the reporting of the total SINS as the final answer.",
            "answer": "$$\\boxed{14}$$"
        },
        {
            "introduction": "Effective clinical leadership involves not only making decisions for individual patients but also evaluating the long-term value and efficiency of different treatment strategies at a population level. This advanced exercise challenges you to build a simplified health-economic model to compare early surgical decompression versus delayed conservative management for cervical spondylotic myelopathy. By deriving the expected Quality-Adjusted Life Years (QALYs) and costs, you will compute the Incremental Cost-Effectiveness Ratio (ICER) , a key metric that informs clinical guidelines and healthcare policy.",
            "id": "4470601",
            "problem": "A neurology department is evaluating two strategies for patients with clinically significant cervical spondylotic myelopathy: early surgical decompression versus delayed conservative management. To support decision-making, you are asked to build a parsimonious continuous-time state-transition model and compute the Incremental Cost-Effectiveness Ratio (ICER) from first principles using stated inputs. Assume the following scientifically grounded framework.\n\nStart from the definition that a Quality-Adjusted Life Year (QALY) is the time integral of health-related utility, discounted at a constant rate, and that costs are likewise discounted. Model disease severity in two health states, mild myelopathy and severe myelopathy, with an absorbing death state. Assume a constant all-cause mortality hazard $\\mu$ from either health state, and a constant progression hazard $\\lambda$ from mild to severe, with no regression. Patients start in mild myelopathy at time $t=0$. Let $u_{\\mathrm{M}}$ and $u_{\\mathrm{S}}$ denote state utilities for mild and severe myelopathy, respectively, and let $c_{\\mathrm{M}}$ and $c_{\\mathrm{S}}$ denote annualized care costs while in those states. Let $C_{\\mathrm{up}}$ denote any upfront strategy-specific cost at $t=0$. Both utilities and costs are discounted continuously at rate $r$ over a finite horizon $T$.\n\nTwo strategies are defined:\n- Early decompression (ED): progression hazard $\\lambda_{\\mathrm{E}}$, utilities $u_{\\mathrm{M}}^{\\mathrm{E}}$, $u_{\\mathrm{S}}^{\\mathrm{E}}$, costs $c_{\\mathrm{M}}^{\\mathrm{E}}$, $c_{\\mathrm{S}}^{\\mathrm{E}}$, upfront cost $C_{\\mathrm{up}}^{\\mathrm{E}}$.\n- Delayed conservative management (DC): progression hazard $\\lambda_{\\mathrm{C}}$, utilities $u_{\\mathrm{M}}^{\\mathrm{C}}$, $u_{\\mathrm{S}}^{\\mathrm{C}}$, costs $c_{\\mathrm{M}}^{\\mathrm{C}}$, $c_{\\mathrm{S}}^{\\mathrm{C}}$, upfront cost $C_{\\mathrm{up}}^{\\mathrm{C}}$.\n\nUse the following parameter values, which are plausible for an older cohort with cervical spondylotic myelopathy:\n- Time horizon $T = 10$ years.\n- Discount rate $r = 0.03$ per year.\n- Mortality hazard $\\mu = 0.04$ per year.\n- Early decompression: $\\lambda_{\\mathrm{E}} = 0.05$ per year, $u_{\\mathrm{M}}^{\\mathrm{E}} = 0.82$, $u_{\\mathrm{S}}^{\\mathrm{E}} = 0.40$, $c_{\\mathrm{M}}^{\\mathrm{E}} = 800$ United States Dollars per year, $c_{\\mathrm{S}}^{\\mathrm{E}} = 6{,}000$ United States Dollars per year, $C_{\\mathrm{up}}^{\\mathrm{E}} = 28{,}000$ United States Dollars.\n- Delayed conservative management: $\\lambda_{\\mathrm{C}} = 0.12$ per year, $u_{\\mathrm{M}}^{\\mathrm{C}} = 0.75$, $u_{\\mathrm{S}}^{\\mathrm{C}} = 0.40$, $c_{\\mathrm{M}}^{\\mathrm{C}} = 600$ United States Dollars per year, $c_{\\mathrm{S}}^{\\mathrm{C}} = 7{,}500$ United States Dollars per year, $C_{\\mathrm{up}}^{\\mathrm{C}} = 0$ United States Dollars.\n\nFrom the base definitions and the continuous-time hazards, derive the expected discounted QALYs and expected discounted costs for each strategy over $[0,T]$. Then compute the Incremental Cost-Effectiveness Ratio (ICER), defined as the ratio of the difference in discounted costs to the difference in discounted QALYs for early decompression versus delayed conservative management. Express the ICER in United States Dollars per Quality-Adjusted Life Year. Round your final ICER to four significant figures.",
            "solution": "The starting point is the definition of the Quality-Adjusted Life Year (QALY) for a strategy as the discounted integral of utility over time. With continuous discounting at rate $r$, and transient state probabilities $P_{\\mathrm{M}}(t)$ and $P_{\\mathrm{S}}(t)$ for mild and severe myelopathy respectively, the expected discounted QALYs over horizon $[0,T]$ are\n$$\nQ = \\int_{0}^{T} \\Big(u_{\\mathrm{M}} P_{\\mathrm{M}}(t) + u_{\\mathrm{S}} P_{\\mathrm{S}}(t)\\Big) \\exp(-r t) dt.\n$$\nSimilarly, the expected discounted costs are\n$$\nC = C_{\\mathrm{up}} + \\int_{0}^{T} \\Big(c_{\\mathrm{M}} P_{\\mathrm{M}}(t) + c_{\\mathrm{S}} P_{\\mathrm{S}}(t)\\Big) \\exp(-r t) dt.\n$$\n\nWe construct the transient state probabilities from the continuous-time hazards. The process starts in mild myelopathy at $t=0$ and leaves mild due to either progression to severe at rate $\\lambda$ or death at rate $\\mu$. Therefore the probability of remaining in mild at time $t$ is\n$$\nP_{\\mathrm{M}}(t) = \\exp\\big(-(\\lambda + \\mu) t\\big).\n$$\nTo be in severe at time $t$, the patient must have progressed at some time $s \\in [0,t]$ while still alive and then survived in severe without death until $t$. The density of progression at time $s$ is $\\lambda \\exp\\big(-(\\lambda+\\mu) s\\big)$, and the survival from $s$ to $t$ in severe is $\\exp\\big(-\\mu (t-s)\\big)$. Integrating over possible progression times yields\n\\begin{align*}\nP_{\\mathrm{S}}(t)\n&= \\int_{0}^{t} \\lambda \\exp\\big(-(\\lambda+\\mu) s\\big) \\exp\\big(-\\mu (t-s)\\big) ds \\\\\n&= \\lambda \\exp(-\\mu t) \\int_{0}^{t} \\exp(-\\lambda s) ds \\\\\n&= \\exp(-\\mu t) \\big(1 - \\exp(-\\lambda t)\\big).\n\\end{align*}\nThese expressions ensure that $P_{\\mathrm{M}}(t) + P_{\\mathrm{S}}(t) + P_{\\mathrm{D}}(t) = 1$, with $P_{\\mathrm{D}}(t)$ the probability of being dead by time $t$.\n\nSubstituting $P_{\\mathrm{M}}(t)$ and $P_{\\mathrm{S}}(t)$ into the QALY integral gives\n\\begin{align*}\nQ\n&= \\int_{0}^{T} \\Big(u_{\\mathrm{M}} \\exp\\big(-(\\lambda+\\mu) t\\big) + u_{\\mathrm{S}} \\exp(-\\mu t) \\big(1 - \\exp(-\\lambda t)\\big)\\Big) \\exp(-r t) dt \\\\\n&= u_{\\mathrm{M}} \\int_{0}^{T} \\exp\\big(-(\\lambda+\\mu+r) t\\big) dt \\\\\n&\\quad + u_{\\mathrm{S}} \\left[ \\int_{0}^{T} \\exp\\big(-(\\mu + r) t\\big) dt - \\int_{0}^{T} \\exp\\big(-(\\lambda+\\mu+r) t\\big) dt \\right].\n\\end{align*}\nDefine the function\n$$\nI(a) = \\int_{0}^{T} \\exp\\big(-(a + r) t\\big) dt = \\frac{1 - \\exp\\big(-(a + r) T\\big)}{a + r}.\n$$\nThen, recognizing $a = \\lambda+\\mu$ and $a = \\mu$, we can write\n$$\nQ = u_{\\mathrm{M}} \\frac{1 - \\exp\\big(-(\\lambda+\\mu+r) T\\big)}{\\lambda+\\mu+r} + u_{\\mathrm{S}} \\left( \\frac{1 - \\exp\\big(-(\\mu+r) T\\big)}{\\mu+r} - \\frac{1 - \\exp\\big(-(\\lambda+\\mu+r) T\\big)}{\\lambda+\\mu+r} \\right).\n$$\nEquivalently,\n$$\nQ = u_{\\mathrm{S}} \\frac{1 - \\exp\\big(-(\\mu+r) T\\big)}{\\mu+r} + (u_{\\mathrm{M}} - u_{\\mathrm{S}}) \\frac{1 - \\exp\\big(-(\\lambda+\\mu+r) T\\big)}{\\lambda+\\mu+r}.\n$$\n\nBy the same method, the expected discounted costs are\n\\begin{align*}\nC\n&= C_{\\mathrm{up}} + c_{\\mathrm{M}} \\int_{0}^{T} \\exp\\big(-(\\lambda+\\mu+r) t\\big) dt + c_{\\mathrm{S}} \\left[ \\int_{0}^{T} \\exp\\big(-(\\mu+r) t\\big) dt - \\int_{0}^{T} \\exp\\big(-(\\lambda+\\mu+r) t\\big) dt \\right] \\\\\n&= C_{\\mathrm{up}} + c_{\\mathrm{S}} \\frac{1 - \\exp\\big(-(\\mu+r) T\\big)}{\\mu+r} + (c_{\\mathrm{M}} - c_{\\mathrm{S}}) \\frac{1 - \\exp\\big(-(\\lambda+\\mu+r) T\\big)}{\\lambda+\\mu+r}.\n\\end{align*}\n\nWe now compute these quantities for each strategy using the given parameters $T = 10$, $r = 0.03$, $\\mu = 0.04$.\n\nFirst compute shared terms:\n\\begin{align*}\n\\mu + r &= 0.04 + 0.03 = 0.07, \\\\\n\\exp\\big(-(\\mu+r) T\\big) &= \\exp(-0.07 \\cdot 10) = \\exp(-0.7) \\approx 0.4965853038, \\\\\n\\frac{1 - \\exp\\big(-(\\mu+r) T\\big)}{\\mu+r} &= \\frac{1 - 0.4965853038}{0.07} \\approx \\frac{0.5034146962}{0.07} \\approx 7.1916385173.\n\\end{align*}\n\nFor early decompression (ED), $\\lambda_{\\mathrm{E}} = 0.05$ gives\n\\begin{align*}\n\\lambda_{\\mathrm{E}} + \\mu + r &= 0.05 + 0.04 + 0.03 = 0.12, \\\\\n\\exp\\big(-(\\lambda_{\\mathrm{E}}+\\mu+r) T\\big) &= \\exp(-0.12 \\cdot 10) = \\exp(-1.2) \\approx 0.3011942119, \\\\\n\\frac{1 - \\exp\\big(-(\\lambda_{\\mathrm{E}}+\\mu+r) T\\big)}{\\lambda_{\\mathrm{E}}+\\mu+r} &= \\frac{1 - 0.3011942119}{0.12} \\approx \\frac{0.6988057881}{0.12} \\approx 5.8233815674.\n\\end{align*}\nThus,\n\\begin{align*}\nQ_{\\mathrm{E}}\n&= u_{\\mathrm{S}}^{\\mathrm{E}} \\frac{1 - \\exp\\big(-(\\mu+r) T\\big)}{\\mu+r} + \\big(u_{\\mathrm{M}}^{\\mathrm{E}} - u_{\\mathrm{S}}^{\\mathrm{E}}\\big) \\frac{1 - \\exp\\big(-(\\lambda_{\\mathrm{E}}+\\mu+r) T\\big)}{\\lambda_{\\mathrm{E}}+\\mu+r} \\\\\n&= 0.40 \\cdot 7.1916385173 + (0.82 - 0.40) \\cdot 5.8233815674 \\\\\n&\\approx 2.8766554069 + 0.42 \\cdot 5.8233815674 \\\\\n&\\approx 2.8766554069 + 2.4458202583 \\\\\n&\\approx 5.3224756652.\n\\end{align*}\nAnd\n\\begin{align*}\nC_{\\mathrm{E}}\n&= C_{\\mathrm{up}}^{\\mathrm{E}} + c_{\\mathrm{S}}^{\\mathrm{E}} \\frac{1 - \\exp\\big(-(\\mu+r) T\\big)}{\\mu+r} + \\big(c_{\\mathrm{M}}^{\\mathrm{E}} - c_{\\mathrm{S}}^{\\mathrm{E}}\\big) \\frac{1 - \\exp\\big(-(\\lambda_{\\mathrm{E}}+\\mu+r) T\\big)}{\\lambda_{\\mathrm{E}}+\\mu+r} \\\\\n&= 28{,}000 + 6{,}000 \\cdot 7.1916385173 + (800 - 6{,}000) \\cdot 5.8233815674 \\\\\n&= 28{,}000 + 43{,}149.831104 - 30{,}281.584150 \\\\\n&\\approx 40{,}868.246953.\n\\end{align*}\n\nFor delayed conservative management (DC), $\\lambda_{\\mathrm{C}} = 0.12$ gives\n\\begin{align*}\n\\lambda_{\\mathrm{C}} + \\mu + r &= 0.12 + 0.04 + 0.03 = 0.19, \\\\\n\\exp\\big(-(\\lambda_{\\mathrm{C}}+\\mu+r) T\\big) &= \\exp(-0.19 \\cdot 10) = \\exp(-1.9) \\approx 0.1495686192, \\\\\n\\frac{1 - \\exp\\big(-(\\lambda_{\\mathrm{C}}+\\mu+r) T\\big)}{\\lambda_{\\mathrm{C}}+\\mu+r} &= \\frac{1 - 0.1495686192}{0.19} \\approx \\frac{0.8504313808}{0.19} \\approx 4.4759546357.\n\\end{align*}\nThus,\n\\begin{align*}\nQ_{\\mathrm{C}}\n&= u_{\\mathrm{S}}^{\\mathrm{C}} \\frac{1 - \\exp\\big(-(\\mu+r) T\\big)}{\\mu+r} + \\big(u_{\\mathrm{M}}^{\\mathrm{C}} - u_{\\mathrm{S}}^{\\mathrm{C}}\\big) \\frac{1 - \\exp\\big(-(\\lambda_{\\mathrm{C}}+\\mu+r) T\\big)}{\\lambda_{\\mathrm{C}}+\\mu+r} \\\\\n&= 0.40 \\cdot 7.1916385173 + (0.75 - 0.40) \\cdot 4.4759546357 \\\\\n&\\approx 2.8766554069 + 0.35 \\cdot 4.4759546357 \\\\\n&\\approx 2.8766554069 + 1.5665841225 \\\\\n&\\approx 4.4432395294.\n\\endalign*}\nAnd\n\\begin{align*}\nC_{\\mathrm{C}}\n&= C_{\\mathrm{up}}^{\\mathrm{C}} + c_{\\mathrm{S}}^{\\mathrm{C}} \\frac{1 - \\exp\\big(-(\\mu+r) T\\big)}{\\mu+r} + \\big(c_{\\mathrm{M}}^{\\mathrm{C}} - c_{\\mathrm{S}}^{\\mathrm{C}}\\big) \\frac{1 - \\exp\\big(-(\\lambda_{\\mathrm{C}}+\\mu+r) T\\big)}{\\lambda_{\\mathrm{C}}+\\mu+r} \\\\\n&= 0 + 7{,}500 \\cdot 7.1916385173 + (600 - 7{,}500) \\cdot 4.4759546357 \\\\\n&= 53{,}937.288879 - 30{,}884.086986 \\\\\n&\\approx 23{,}053.201893.\n\\end{align*}\n\nThe increments are\n\\begin{align*}\n\\Delta Q &= Q_{\\mathrm{E}} - Q_{\\mathrm{C}} \\approx 5.3224756652 - 4.4432395294 \\approx 0.8792361358, \\\\\n\\Delta C &= C_{\\mathrm{E}} - C_{\\mathrm{C}} \\approx 40{,}868.246953 - 23{,}053.201893 \\approx 17{,}815.045060.\n\\end{align*}\nTherefore, the Incremental Cost-Effectiveness Ratio (ICER) for early decompression versus delayed conservative management is\n$$\n\\mathrm{ICER} = \\frac{\\Delta C}{\\Delta Q} \\approx \\frac{17{,}815.045060}{0.8792361358} \\approx 20{,}261.9573.\n$$\n\nRounded to four significant figures and expressed in United States Dollars per Quality-Adjusted Life Year, the ICER is $20{,}260$ United States Dollars per Quality-Adjusted Life Year. In scientific notation with four significant figures, this is $2.026 \\times 10^{4}$.",
            "answer": "$$\\boxed{2.026 \\times 10^{4}}$$"
        }
    ]
}